Nursing Elites

1. Which disease is characterized by the damage to the alveoli in the lungs, leading to breathlessness?

• A. Emphysema
• B. Pulmonary fibrosis
• C. Lung cancer
• D. Lung abscess

Correct answer: A

Rationale: The correct answer is A, Emphysema. Emphysema is a lung condition characterized by the damage to the air sacs (alveoli) in the lungs, which results in breathlessness and reduced lung function. Pulmonary fibrosis (B) is a condition where lung tissue becomes damaged and scarred, leading to stiffness in the lungs. Lung cancer (C) is a malignancy affecting the lungs, which can cause various symptoms depending on the stage. Lung abscess (D) is a localized collection of pus within the lung tissue, typically caused by a bacterial infection.

2. Which condition involves the enlargement and weakening of the left ventricle of the heart, leading to reduced pumping ability?

• A. Dilated cardiomyopathy
• B. Hypertrophic cardiomyopathy
• C. Restrictive cardiomyopathy
• D. Pericarditis

Correct answer: A

Rationale: The correct answer is A: Dilated cardiomyopathy. Dilated cardiomyopathy is characterized by the enlargement and weakening of the left ventricle of the heart, which results in a reduced ability to pump blood effectively. Choice B, Hypertrophic cardiomyopathy, involves thickening of the heart muscle, not enlargement. Choice C, Restrictive cardiomyopathy, is characterized by stiffening of the heart muscle, not enlargement. Choice D, Pericarditis, refers to inflammation of the pericardium, the lining surrounding the heart, and does not involve enlargement and weakening of the left ventricle.

3. From where do these originate, behind the cusps of the aortic valve, in an area known as Valsalva’s sinus?

• A. Pulmonary valve
• B. Aortic valve
• C. Tricuspid valve
• D. Mitral valve

Correct answer: B

Rationale: The correct answer is B, Aortic valve. The aortic valve is a semilunar valve located between the left ventricle and the aorta. It prevents the backflow of blood from the aorta into the left ventricle. The pulmonary valve (choice A) is located between the right ventricle and the pulmonary artery, not in the Valsalva’s sinus area. The tricuspid valve (choice C) is situated between the right atrium and right ventricle, and the mitral valve (choice D) is located between the left atrium and left ventricle, making them incorrect choices for this question.

4. Which type of heart disease involves the stiffening of the heart muscle, reducing its ability to relax and fill with blood?

• A. Restrictive cardiomyopathy
• B. Hypertrophic cardiomyopathy
• C. Dilated cardiomyopathy
• D. Ventricular hypertrophy

Correct answer: A

Rationale: The correct answer is A, restrictive cardiomyopathy. This condition specifically involves the stiffening of the heart muscle, leading to a reduced ability to relax and fill with blood between beats. Choice B, hypertrophic cardiomyopathy, is characterized by abnormal thickening of the heart muscle, not stiffening. Choice C, dilated cardiomyopathy, involves the enlargement and weakening of the heart chambers, not stiffening. Choice D, ventricular hypertrophy, refers to the thickening of the walls of the heart's pumping chambers but does not specifically involve the stiffening that is characteristic of restrictive cardiomyopathy.

5. The client is on digoxin and has severe digoxin toxicity. What is the nursing priority action?

• A. Check the potassium level.
• B. Give Digibind as an antidote.
• C. Change the dosing of digoxin to every other day.
• D. Administer a potassium supplement to decrease digoxin toxicity.

Correct answer: B

Rationale: The correct answer is to give Digibind as an antidote in cases of severe digoxin toxicity. Digibind works by binding to digoxin and preventing it from causing further harm. Checking the potassium level (choice A) is important but not the priority when the client has severe toxicity. Changing the dosing to every other day (choice C) is not appropriate in the setting of severe toxicity where immediate action is required. Giving a potassium supplement (choice D) may be needed eventually, but the priority is to administer Digibind to counteract the toxic effects of digoxin.

Similar Questions